New award for lurasidone HCL tablets with the harvard drug group, L.L.C. DBA major pharmaceuticals. Base year ordering period is 12/10/2024 to 12/09/2025 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0001
- Awardee
-
The Harvard Drug Group, L.L.C. UEI CBGGKKVNJBK9 Part of Cardinal Health, Inc.
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Lurasidone Tablets (VA-24-00084543) Pre-Solicitation · 36E79724R0022 · Posted Jul 16, 2024
- Last date to order 95% complete
- IDV ceiling
- $10,056,938.10
- Award type
- Single award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to The Harvard Drug Group, L.L.C. for Lurasidone Hydrochloride tablets on December 10, 2024, with a ceiling of $10,056,938.10. The Harvard Drug Group is a Native Hawaiian Organization-owned subsidiary of Cardinal Health, Inc.
The procurement carries no set-aside designation. Place of performance is La Vergne, Tennessee. The contract was solicited as a commercial item acquisition to serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center with an uninterrupted pharmaceutical supply. The solicitation specified estimated annual usage quantities ranging from 23,754 bottles at 120mg strength to 59,189 bottles at 40mg strength; offerors were required to provide a unique National Drug Code number and label.
The base year ordering period runs from December 10, 2024 through December 9, 2025, with four one-year option periods extending the ultimate completion date to December 9, 2026. NAICS code 325412 (Pharmaceutical Preparation Manufacturing) applies. The contract is registered as a child contract under a modification to implement Executive Order 14398 regarding discrimination in federal contracts, numbered 36E79725D0001.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0001?
36E79725D0001 was awarded to The Harvard Drug Group, L.L.C. by National Acquisition Center (Headquarters) on December 10, 2024.
How much is contract 36E79725D0001 worth?
36E79725D0001's own ceiling is $10,056,938.
Who can order from contract 36E79725D0001?
36E79725D0001 is a single award indefinite delivery contract. All agencies can place orders on it.
Was contract 36E79725D0001 competed?
The extent of competition for 36E79725D0001 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV